Form 4 filed by Gline Matthew
Gline Matthew filed this Form 4 on ROIV (Roivant Sciences Ltd.) with 7 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-13 02:01:02 UTC.
- Accession
- 0001635088-26-000147
- Filer
- CIK 1750094
- Filed
- 2026-11-12
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: ROIV · Roivant Sciences Ltd. (CIK 1635088)
- Gline Matthew director, officer (CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Shares | 2026-11-10 | J other | -25,841 | $40.43 | 16,523,295 | D |
| Common Shares | 2026-11-10 | J other | -32,490 | $41.13 | 16,490,805 | D |
| Common Shares | 2026-11-11 | J other | -30,083 | $41.63 | 16,460,722 | D |
| Common Shares | 2026-11-11 | J other | -18,905 | $42.01 | 16,441,817 | D |
| Common Shares | 2026-11-12 | J other | -41,179 | $40.36 | 16,400,638 | D |
| Common Shares | 2026-11-12 | J other | -7,809 | $41.13 | 16,392,829 | D |
| Common Shares | 2026-11-12 | F withheld for tax | -1,600 | $41.85 | 16,391,229 | D |